1-Aminomethylisoquinoline-4-carboxylates as novel dipeptidylpeptidase IV inhibitors

This publication has 12 references indexed in Scilit:

• ISOQUINOLINE-BASED AMINO ACID DERIVATIVES
  hc, 2000
• NVP-DPP728 (1-[[[2-[(5-Cyanopyridin-2-yl)amino]ethyl]amino]acetyl]-2-cyano-(S)-pyrrolidine), a Slow-Binding Inhibitor of Dipeptidyl Peptidase IV
  Biochemistry, 1999
• Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes.
  Diabetes, 1998
• Economic Consequences of Diabetes Mellitus in the U.S. in 1997
  Diabetes Care, 1998
• Glucagon-Like Peptide 1 and its Potential in the Treatment of Non-Insulin-Dependent Diabetes Mellitus
  Hormone and Metabolic Research, 1997
• Glucagon-like peptide 1 (GLP-1) as a new therapeutic approach for Type 2-diabetes
  Experimental and Clinical Endocrinology & Diabetes, 1997
• Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects
  Diabetes, 1995
• Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo
  Journal of Clinical Endocrinology & Metabolism, 1995
• Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patients
  Diabetologia, 1993
• Dipeptidyl‐peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon‐like peptide‐1(7–36)amide, peptide histidine methionine and is responsible for their degradation in human serum
  European Journal of Biochemistry, 1993